ResearcherAsan Medical CenterNo recent work listed
Eun Kyung Choi
Matched on ORCID iD 0000-0002-5265-7640; OpenAlex author ID A5084662421. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2015: 1 paper · 2016: 3 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 6
- Orthotopic model of pancreatic cancer using CD34+ humanized mice and generation of tumor organoids from humanized tumors. Co-author DOI 10.1016/j.intimp.2023.110451↗
- Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin. Co-author DOI 10.21873/anticanres.11374↗
- SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin. Co-author DOI 10.1007/s13277-015-4216-2↗
- Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer m… Last author DOI 10.18632/oncotarget.12668↗
- Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma. Co-author PMID 26851005↗
- A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic … Co-author DOI 10.18632/oncotarget.4822↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- In Kyong Shim · 2 shared papers, 2016–2023 · strength 0.24
- Paper Orthotopic model of pancreatic cancer using CD34+ humanized mice and generation of tumor organoids from humanized tumor… DOI 10.1016/j.intimp.2023.110451↗
- Paper Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ducta… PMID 26851005↗
- Eunsung Jun · 2 shared papers, 2016–2023 · strength 0.24
- Paper Orthotopic model of pancreatic cancer using CD34+ humanized mice and generation of tumor organoids from humanized tumor… DOI 10.1016/j.intimp.2023.110451↗
- Paper Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ducta… PMID 26851005↗
- Kyu‐pyo Kim · 4 shared papers, 2015–2017 · strength 0.19
- Paper Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin. DOI 10.21873/anticanres.11374↗
- Paper Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical dat… DOI 10.18632/oncotarget.12668↗
- Paper SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin. DOI 10.1007/s13277-015-4216-2↗
- Ji Hye Jeong · 1 shared paper, 2023 · strength 0.18
- Jinju Kim · 1 shared paper, 2023 · strength 0.18
- Seung‐Mo Hong · 2 shared papers, 2016–2017 · strength 0.11
- Song Cheol Kim · 2 shared papers, 2016–2017 · strength 0.11
- Jai-Hee Moon · 2 shared papers, 2015–2016 · strength 0.08
- Paper SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin. DOI 10.1007/s13277-015-4216-2↗
- Paper A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targetin… DOI 10.18632/oncotarget.4822↗
- Tae Won Kim · 2 shared papers, 2015–2016 · strength 0.08
- Paper SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin. DOI 10.1007/s13277-015-4216-2↗
- Paper A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targetin… DOI 10.18632/oncotarget.4822↗
- Ki Byung Song · 1 shared paper, 2017 · strength 0.05
- Jong Hoon Kim · 1 shared paper, 2017 · strength 0.05
- Jin‐hong Park · 1 shared paper, 2017 · strength 0.05
- Dae Wook Hwang · 1 shared paper, 2017 · strength 0.05
- Sunmin Park · 1 shared paper, 2017 · strength 0.05
- Baek‐Yeol Ryoo · 1 shared paper, 2017 · strength 0.05
- Young Joo Lee · 1 shared paper, 2017 · strength 0.05
- Joohee Jung · 1 shared paper, 2016 · strength 0.05
- Si Yeol Song · 1 shared paper, 2016 · strength 0.05
- Suhwan Chang · 1 shared paper, 2016 · strength 0.05
- Changmo Hwang · 1 shared paper, 2016 · strength 0.05
- Robert M. Hoffman · 1 shared paper, 2016 · strength 0.05
- Seongjoon Park · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.